Five Prime Therapeutics Stock Price - FPRX

4.32
0.00 (0.00%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Five Prime Therapeutics Inc FPRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.51 -10.56% 4.32 4.27 4.72 4.70 4.83 16:30:00
Bid Price Ask Price Spread Spread % News
4.20 5.30 1.10 20.75% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,933 604,731 $ 4.48 $ 2,706,349 470,434 2.33 - 13.84
Last Trade Time Type Quantity Stock Price Currency
16:29:19 formt 3,000 $ 4.32 USD

Five Prime Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 157.21M 36.39M $ -140.45M -4.11 - 35.26M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Five Prime Therapeutics News

Date Time Source News Article
2/27/202016:18Edgar (US Regulatory)Current Report Filing (8-k)
2/27/202016:05Business WireFive Prime Therapeutics Reports Fourth Quarter and Full Year..
2/26/202016:07Edgar (US Regulatory)Current Report Filing (8-k)
2/25/202016:22Business WireFive Prime Therapeutics to Present at Upcoming Healthcare..
2/19/202010:31Dow Jones NewsFive Prime Therapeutics In License Agreement with Seattle..
2/19/202009:25Business WireFive Prime Therapeutics Licenses Antibodies to Seattle..
2/18/202010:35Dow Jones NewsFive Prime: Phase 2 Cabiralizumab/Opdivo Study Misses..

Latest FPRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FPRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.245.79994.275.17420,893-0.92-17.56%
1 Month5.195.79992.334.94416,340-0.87-16.76%
3 Months3.966.212.334.84478,2170.369.09%
6 Months5.606.382.334.51412,118-1.28-22.86%
1 Year11.9213.842.336.13380,088-7.60-63.76%
3 Years46.2648.872.3317.61395,774-41.94-90.66%
5 Years27.5060.982.3325.52400,044-23.18-84.29%

Five Prime Therapeutics Description

Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. Its is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in pipeline: Cabiralizumab, FPA150, Bemarituzumab and Immuno-Oncology.
Your Recent History
NASDAQ
FPRX
Five Prime..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200227 22:01:04